Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid + Irinotecan in Advanced Colorectal Cancer
NCT01550510Phase 2Terminated
- Sponsor
- Thomas Jefferson University
- Start
- Dec 2011
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in colorectal cancer (CRC), sponsored by Thomas Jefferson University. Started Dec 2011; status: terminated.
02
Drugs
ascorbic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01550510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01550510.